Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
株式のランク #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
株価
$1.84
最終同期: 2026-08-21
時価総額
$66.03M
変化(1日)
0.00%
変化(1年)
-8.25%
ES
取引 Pangaea Oncology, S.A. (PANG)

カテゴリー

Pangaea Oncology, S.A.(PANG)の株価履歴
終値の最高値: $1.84 (2026-08-01)

終値の最安値: $2.93 (2017-09-01)
Pangaea Oncology, S.A. の株価履歴(2017 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -2.66%
2025 8.06%
2024 15.26%
2023 2.98%
2022 -25.56%
2021 6.89%
2020 3.56%
2019 -27.13%
2018 -12.00%
2017 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US